These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 33061603)
1. The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma. Jiang P; Han W; Fu Y; Chen Q Cancer Manag Res; 2020; 12():9087-9096. PubMed ID: 33061603 [TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis. Zhu Z; Shen S; Zhao S; Wang Z Onco Targets Ther; 2020; 13():11301-11313. PubMed ID: 33177838 [TBL] [Abstract][Full Text] [Related]
3. CircRNA hsa_circ_0030018 regulates the development of glioma via regulating the miR-1297/RAB21 axis. Song D; Ye L; Xu Z; Jin Y; Zhang L Neoplasma; 2021 Mar; 68(2):391-403. PubMed ID: 33440987 [TBL] [Abstract][Full Text] [Related]
4. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis. Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214 [TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0016788 regulates hepatocellular carcinoma progression via miR-506-3p/poly-adenosine diphosphate-ribose polymerase. Chen M; Hu G; Zhou X; Peng Z; Wen W J Gastroenterol Hepatol; 2021 Dec; 36(12):3457-3468. PubMed ID: 34340259 [TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis. He S; Yang J; Jiang S; Li Y; Han X Cancer Cell Int; 2020; 20():404. PubMed ID: 32863763 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis. Gong J; Du C; Sun N; Xiao X; Wu H J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904 [TBL] [Abstract][Full Text] [Related]
8. circRNA Hsa_circ_0020850 Silence Represses the Development of Lung Adenocarcinoma via Regulating miR-195-5p/IRS2 Axis. Xin T; Li S; Zhang Y; Kamali X; Liu H; Jia T Cancer Manag Res; 2020; 12():10679-10692. PubMed ID: 33149675 [TBL] [Abstract][Full Text] [Related]
9. Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis. Zhao L; Ma N; Liu G; Mao N; Chen F; Li J Dig Dis Sci; 2021 Dec; 66(12):4384-4397. PubMed ID: 33433806 [TBL] [Abstract][Full Text] [Related]
10. Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis. Jia Y; Li S; Zhang M; Zhang Z; Wang C; Zhang C; Yang W; Peng L; Xu Z Cancer Manag Res; 2021; 13():337-349. PubMed ID: 33469375 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis. He S; Guo Z; Kang Q; Wang X; Han X Cancer Cell Int; 2020; 20():360. PubMed ID: 32774154 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel inhibits hepatocellular carcinoma tumorigenesis by regulating the circ_0005785/miR-640/GSK3β. Yang X; Tian X; Zhao P; Wang Z; Sun X Cell Biol Int; 2023 Jul; 47(7):1170-1182. PubMed ID: 37269228 [TBL] [Abstract][Full Text] [Related]
13. Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis. Li Y; Zang H; Zhang X; Huang G Cancer Manag Res; 2020; 12():7739-7751. PubMed ID: 32943922 [TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis. Si H; Wang H; Xiao H; Fang Y; Wu Z Cancer Manag Res; 2021; 13():1099-1111. PubMed ID: 33574707 [TBL] [Abstract][Full Text] [Related]
15. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Liu L; Yang X; Li NF; Lin L; Luo H Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588 [No Abstract] [Full Text] [Related]
16. Circ_0000854 regulates the progression of hepatocellular carcinoma through miR-1294 /IRGQ axis. Lin G; Li J; Chen K; Wang A; Guo C Clin Immunol; 2022 May; 238():109007. PubMed ID: 35417749 [TBL] [Abstract][Full Text] [Related]
17. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis. Liu H; Cheng J; Xu H; Wan Z Open Life Sci; 2021; 16(1):766-780. PubMed ID: 34435133 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of circ-TTBK2 Inhibits Glioma Progression by Regulating miR-1283 and CHD1. Han C; Wang S; Wang H; Zhang J Cancer Manag Res; 2020; 12():10055-10065. PubMed ID: 33116862 [TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression. Lu Z; Wang C; Lv X; Dai W J Bone Oncol; 2021 Jun; 28():100360. PubMed ID: 33996428 [TBL] [Abstract][Full Text] [Related]
20. Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis. Lin T; Dai Y; Guo X; Chen W; Zhao J; Cao L; Wu Z Cancer Manag Res; 2019; 11():9133-9143. PubMed ID: 31695501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]